PMA device
Edwards Commander Delivery System
Edwards Lifesciences, LLC · Pulmonary Valve Prosthesis Percutaneously Delivered (NPV, ) · First FDA decision Jun 29, 2021, newest Apr 4, 2023Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
5
Naming "Edwards Commander"
MAUDE reports
3,764
Brand "Edwards Commander", since 2015
PubMed studies
7
Mentioning "Edwards Commander"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Edwards Commander Delivery System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Edwards Commander Delivery SystemPMA supplement
P200015-S029 · Decided Apr 4, 2023 · 207 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
- Edwards Commander Delivery SystemPMA supplement
P200015-S026 · Decided Mar 9, 2023 · 212 days after receipt · Normal 180 Day Track
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
- Edwards Commander Delivery System, CrimperPMA supplement
P200015-S010 · Decided Jun 29, 2021 · 22 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Edwards Commander", any status and sponsor, newest update first.
- ALTERRA: SAPIEN 3 THV With the Alterra Adaptive PrestentActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT03130777 · 86 participants · Start Aug 22, 2017 · Primary completion Jul 14, 2022
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV · For: Pulmonary Disease; Transcatheter Pulmonary Valve Replacement (TPVR); Tetralogy of Fallot and 2 more
Sites: Los Angeles, California; San Francisco, California; Aurora, Colorado · 14 sites in all
- PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic StenosisPivotal-lookingActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT02675114 · 1,000 participants · Start Mar 2016 · Primary completion Nov 16, 2020
Device: SAPIEN 3 THV · For: Aortic Stenosis
Sites: Birmingham, Alabama; Phoenix, Arizona; Burlingame, California · 77 sites in all
- China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese PopulationCompleted
Edwards LifesciencesPublic (EW)
NCT03466918 · 58 participants · Start May 23, 2018 · Primary completion Jul 3, 2019
Device: SAPIEN 3 THV with the Commander delivery system · For: Aortic Stenosis; Symptomatic Aortic Stenosis; Aortic Regurgitation
Sites: Beijing, China; Chengdu, China; Hangzhou, China · 4 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Edwards Commander", and for the whole product code for context.
This brand
3,764 reports: 1,776 malfunction, 1,511 injury, 476 death
Whole product code NPV
2,196 reports: 375 malfunction, 1,749 injury, 72 death
Newest reports for this brand
- Edwards COMMANDER DELIVERY SYSTEMMalfunction
2015691-2026-19834 · Received Oct 29, 2026 · Event dated Oct 8, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Burst Container or Vessel
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Edwards Commander Delivery SystemMalfunction
2015691-2026-19842 · Received Oct 29, 2026 · Event dated Oct 8, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Burst Container or Vessel
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2015691-2026-19796 · Received Oct 28, 2026 · Event dated Oct 2, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Burst Container or Vessel; Difficult to Remove
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Edwards Commander"[tiab]. The summary above synthesizes these.
- Balloon Dilatation of Expandable Sheath to Facilitate Transfemoral SAPIEN 3 Transcatheter Aortic Valve Replacement in Severely Calcified Vasculature.
Gedela M, Khera S, Tadros RO, et al. · J Soc Cardiovasc Angiogr Interv · 2022
- Next-generation balloon-expandable transcatheter heart valve: the SAPIEN 3 Ultra valve.
Chatfield A, Sathananthan J, Wood DA, et al. · Future Cardiol · 2021Research Support, Non-U.S. Gov't
- Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement.
Koehler T, Buege M, Schleiting H, et al. · Biomed Res Int · 2015
- Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
Zablah JE, Døhlen G, Ystgaard MB, et al. · Catheter Cardiovasc Interv · 2022
- Transcatheter Aortic Valve Replacement via the Right Subclavian Artery Approach: A Case Series.
Pisaniello AD, Fraser DGW, Colville H, et al. · Innovations (Phila) · 2021
- 4-Dimensional Intracardiac Echocardiography-Guided Antegrade TAVR Using a Novel CABLE-TAVR Technique.
Robin KJ, Campbell JM, Castellanos JA · JACC Case Rep · 2026Case Reports
- Simultaneous Transcatheter Intervention for Coarctation of the Aorta and Bicuspid Aortic Valve.
Mizutani Y, Tada N, Masuda T, et al. · J Heart Valve Dis · 2017Case Reports
Other devices of this type
Also filed under product code NPV.
- SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive PrestentEdwards Lifesciences, LLC · PMA 2026
- Harmony TPV SystemMedtronic, Inc. · PMA 2026
- Melody Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2017
- Edwards Alterra Adaptive Prestent SystemEdwards Lifesciences, LLC · PMA 2022
- Harmony Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2022
- 9600CR CrimperEdwards Lifesciences, LLC · PMA 2022
- Melody TPV SystemMedtronic, Inc. · PMA 2019
- Ensemble II Transcatheter Valve Delivery SystemMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.